組織質量分析イメージング・システムの世界市場成長 2023-2029Global Tissue Mass Spectrometry Imaging System Market Growth 2023-2029 弊社(LP Info Research)の最新調査によると、世界の組織質量分析イメージングシステム市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー弊社(LP Info Research)の最新調査によると、世界の組織質量分析イメージングシステム市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、組織質量分析イメージングシステムはレビュー期間中のCAGR %で2029年までに100万米ドルの再調整規模になると予測されています。この調査レポートは、世界の組織質量分析イメージングシステム市場の成長可能性を明らかにしています。COVID-19やロシア・ウクライナ戦争の影響からの回復に伴い、組織質量分析イメージングシステムは今後の市場でも安定した成長が期待される。しかし、Tissue Mass Spectrometry Imaging Systemの普及には、製品の差別化、コストの削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、Tissue Mass Spectrometry Imaging System市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要がある。 質量分析イメージングとは、質量分析技術に基づくイメージング手法である。この方法は、質量分析を通してイメージングするために生物学的サンプルを直接スキャンし、同じ組織スライスまたは組織チップ上の数百の分子の空間分布特性を同時に分析することができる。簡単に言えば、質量分析イメージング技術とは、質量電荷比を決定することで生体分子の標準分子量を分析する質量分析計を用い、専用の質量分析イメージングソフトウェアの制御と相まって、質量分析の助けを借りてイメージングを行う方法である。組織質量分析イメージングシステムは、高パラメータの単一細胞懸濁液検出機能と組織イメージング機能の両方を備えています。組織イメージング研究において、質量分析フローサイトメトリー(CyTOF)超多数の検出チャンネルの利点を最大限に生かし、その性能は従来の免疫組織化学や免疫蛍光技術をはるかに凌ぐ。 主な特徴 Tissue Mass Spectrometry Imaging System市場に関するレポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、組織質量分析イメージングシステム市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(例:検出チャンネルが100未満、検出チャンネルが100以上)、地域別内訳などが含まれます。 市場促進要因と課題:レポートでは、政府規制、環境問題、技術進歩、消費者の嗜好の変化など、組織質量分析イメージングシステム市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、測定範囲への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。 競合情勢:この調査レポートは、組織質量分析イメージングシステム市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興企業や市場に影響を与える可能性のある企業にもスポットを当てています。 技術開発:この調査レポートは、組織質量分析イメージングシステム産業における最新の技術開発を掘り下げることができます。これには、Tissue Mass Spectrometry Imaging System技術の進歩、Tissue Mass Spectrometry Imaging Systemの新規参入企業、Tissue Mass Spectrometry Imaging Systemの新規投資、Tissue Mass Spectrometry Imaging Systemの将来を形作るその他の技術革新などが含まれます。 川下の事業者の好みこの調査レポートは、組織質量分析イメージングシステム市場における顧客の購買行動と採用動向を明らかにします。顧客の購買決定、組織質量分析イメージングシステム製品の嗜好に影響を与える要因も含まれています。 政府の政策とインセンティブこの調査レポートは、政府の政策とインセンティブが組織質量分析イメージングシステム市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、組織マススペクトロメトリーイメージングシステム市場の促進を目的としたその他の施策の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。 環境への影響と持続可能性この調査レポートは、組織質量分析イメージングシステム市場の環境への影響と持続可能性の側面を評価しています。 市場予測と将来展望:調査レポートは、実施した分析に基づいて、組織質量分析イメージングシステム産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、組織質量分析イメージングシステム市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 組織マススペクトロメトリーイメージングシステム市場は、タイプ別と用途別に分割される。2018~2029年の期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント 検出チャネルが100未満 検出チャネルが100以上 用途別セグメント 神経科学 病理学 栄養学 その他 本レポートはまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 スタンダード・バイオツールズ ウォーターズコーポレーション イオンパス 日本電子 島津製作所 トランスミット社 サーモフィッシャーサイエンティフィック インパクト科学機器 mProbe 本レポートで扱う主な質問 世界の組織質量分析イメージングシステム市場の10年展望は? 組織質量分析イメージングシステムの世界市場および地域別市場成長を促進する要因は何か? 市場別、地域別に最も急成長する技術は何か? 組織マススペクトロメトリーイメージングシステムの市場機会は最終市場規模によってどのように異なるのか? Tissue Mass Spectrometry Imaging Systemのタイプ別、用途別の内訳は? COVID-19とロシア・ウクライナ戦争の影響は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Country/Region, 2018, 2022 & 2029 2.2 Tissue Mass Spectrometry Imaging System Segment by Type 2.2.1 Detection Channel Is Less Than 100 2.2.2 Detection Channel Is Greater Than 100 2.3 Tissue Mass Spectrometry Imaging System Sales by Type 2.3.1 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Type (2018-2023) 2.3.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Type (2018-2023) 2.3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Type (2018-2023) 2.4 Tissue Mass Spectrometry Imaging System Segment by Application 2.4.1 Neuroscience 2.4.2 Pathology 2.4.3 Nutrition 2.4.4 Others 2.5 Tissue Mass Spectrometry Imaging System Sales by Application 2.5.1 Global Tissue Mass Spectrometry Imaging System Sale Market Share by Application (2018-2023) 2.5.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Application (2018-2023) 2.5.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Application (2018-2023) 3 Global Tissue Mass Spectrometry Imaging System by Company 3.1 Global Tissue Mass Spectrometry Imaging System Breakdown Data by Company 3.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Company (2018-2023) 3.1.2 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Company (2018-2023) 3.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Company (2018-2023) 3.2.1 Global Tissue Mass Spectrometry Imaging System Revenue by Company (2018-2023) 3.2.2 Global Tissue Mass Spectrometry Imaging System Revenue Market Share by Company (2018-2023) 3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Company 3.4 Key Manufacturers Tissue Mass Spectrometry Imaging System Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Tissue Mass Spectrometry Imaging System Product Location Distribution 3.4.2 Players Tissue Mass Spectrometry Imaging System Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Tissue Mass Spectrometry Imaging System by Geographic Region 4.1 World Historic Tissue Mass Spectrometry Imaging System Market Size by Geographic Region (2018-2023) 4.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Tissue Mass Spectrometry Imaging System Market Size by Country/Region (2018-2023) 4.2.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Country/Region (2018-2023) 4.2.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Country/Region (2018-2023) 4.3 Americas Tissue Mass Spectrometry Imaging System Sales Growth 4.4 APAC Tissue Mass Spectrometry Imaging System Sales Growth 4.5 Europe Tissue Mass Spectrometry Imaging System Sales Growth 4.6 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales Growth 5 Americas 5.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country 5.1.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023) 5.1.2 Americas Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023) 5.2 Americas Tissue Mass Spectrometry Imaging System Sales by Type 5.3 Americas Tissue Mass Spectrometry Imaging System Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region 6.1.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region (2018-2023) 6.1.2 APAC Tissue Mass Spectrometry Imaging System Revenue by Region (2018-2023) 6.2 APAC Tissue Mass Spectrometry Imaging System Sales by Type 6.3 APAC Tissue Mass Spectrometry Imaging System Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Tissue Mass Spectrometry Imaging System by Country 7.1.1 Europe Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023) 7.1.2 Europe Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023) 7.2 Europe Tissue Mass Spectrometry Imaging System Sales by Type 7.3 Europe Tissue Mass Spectrometry Imaging System Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Tissue Mass Spectrometry Imaging System by Country 8.1.1 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023) 8.1.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023) 8.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Type 8.3 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Tissue Mass Spectrometry Imaging System 10.3 Manufacturing Process Analysis of Tissue Mass Spectrometry Imaging System 10.4 Industry Chain Structure of Tissue Mass Spectrometry Imaging System 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Tissue Mass Spectrometry Imaging System Distributors 11.3 Tissue Mass Spectrometry Imaging System Customer 12 World Forecast Review for Tissue Mass Spectrometry Imaging System by Geographic Region 12.1 Global Tissue Mass Spectrometry Imaging System Market Size Forecast by Region 12.1.1 Global Tissue Mass Spectrometry Imaging System Forecast by Region (2024-2029) 12.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Tissue Mass Spectrometry Imaging System Forecast by Type 12.7 Global Tissue Mass Spectrometry Imaging System Forecast by Application 13 Key Players Analysis 13.1 Standard BioTools 13.1.1 Standard BioTools Company Information 13.1.2 Standard BioTools Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.1.3 Standard BioTools Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Standard BioTools Main Business Overview 13.1.5 Standard BioTools Latest Developments 13.2 Waters Corporation 13.2.1 Waters Corporation Company Information 13.2.2 Waters Corporation Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.2.3 Waters Corporation Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Waters Corporation Main Business Overview 13.2.5 Waters Corporation Latest Developments 13.3 Ionpath 13.3.1 Ionpath Company Information 13.3.2 Ionpath Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.3.3 Ionpath Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Ionpath Main Business Overview 13.3.5 Ionpath Latest Developments 13.4 JEOL 13.4.1 JEOL Company Information 13.4.2 JEOL Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.4.3 JEOL Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 JEOL Main Business Overview 13.4.5 JEOL Latest Developments 13.5 SHIMADZU 13.5.1 SHIMADZU Company Information 13.5.2 SHIMADZU Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.5.3 SHIMADZU Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 SHIMADZU Main Business Overview 13.5.5 SHIMADZU Latest Developments 13.6 TransMIT GmbH 13.6.1 TransMIT GmbH Company Information 13.6.2 TransMIT GmbH Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.6.3 TransMIT GmbH Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 TransMIT GmbH Main Business Overview 13.6.5 TransMIT GmbH Latest Developments 13.7 Thermo Fisher Scientific 13.7.1 Thermo Fisher Scientific Company Information 13.7.2 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.7.3 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Thermo Fisher Scientific Main Business Overview 13.7.5 Thermo Fisher Scientific Latest Developments 13.8 Impact Scientific Instrument 13.8.1 Impact Scientific Instrument Company Information 13.8.2 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.8.3 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Impact Scientific Instrument Main Business Overview 13.8.5 Impact Scientific Instrument Latest Developments 13.9 mProbe 13.9.1 mProbe Company Information 13.9.2 mProbe Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.9.3 mProbe Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 mProbe Main Business Overview 13.9.5 mProbe Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our (LP Info Research) latest study, the global Tissue Mass Spectrometry Imaging System market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Tissue Mass Spectrometry Imaging System is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Country/Region, 2018, 2022 & 2029 2.2 Tissue Mass Spectrometry Imaging System Segment by Type 2.2.1 Detection Channel Is Less Than 100 2.2.2 Detection Channel Is Greater Than 100 2.3 Tissue Mass Spectrometry Imaging System Sales by Type 2.3.1 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Type (2018-2023) 2.3.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Type (2018-2023) 2.3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Type (2018-2023) 2.4 Tissue Mass Spectrometry Imaging System Segment by Application 2.4.1 Neuroscience 2.4.2 Pathology 2.4.3 Nutrition 2.4.4 Others 2.5 Tissue Mass Spectrometry Imaging System Sales by Application 2.5.1 Global Tissue Mass Spectrometry Imaging System Sale Market Share by Application (2018-2023) 2.5.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Application (2018-2023) 2.5.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Application (2018-2023) 3 Global Tissue Mass Spectrometry Imaging System by Company 3.1 Global Tissue Mass Spectrometry Imaging System Breakdown Data by Company 3.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Company (2018-2023) 3.1.2 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Company (2018-2023) 3.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Company (2018-2023) 3.2.1 Global Tissue Mass Spectrometry Imaging System Revenue by Company (2018-2023) 3.2.2 Global Tissue Mass Spectrometry Imaging System Revenue Market Share by Company (2018-2023) 3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Company 3.4 Key Manufacturers Tissue Mass Spectrometry Imaging System Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Tissue Mass Spectrometry Imaging System Product Location Distribution 3.4.2 Players Tissue Mass Spectrometry Imaging System Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Tissue Mass Spectrometry Imaging System by Geographic Region 4.1 World Historic Tissue Mass Spectrometry Imaging System Market Size by Geographic Region (2018-2023) 4.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Tissue Mass Spectrometry Imaging System Market Size by Country/Region (2018-2023) 4.2.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Country/Region (2018-2023) 4.2.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Country/Region (2018-2023) 4.3 Americas Tissue Mass Spectrometry Imaging System Sales Growth 4.4 APAC Tissue Mass Spectrometry Imaging System Sales Growth 4.5 Europe Tissue Mass Spectrometry Imaging System Sales Growth 4.6 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales Growth 5 Americas 5.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country 5.1.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023) 5.1.2 Americas Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023) 5.2 Americas Tissue Mass Spectrometry Imaging System Sales by Type 5.3 Americas Tissue Mass Spectrometry Imaging System Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region 6.1.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region (2018-2023) 6.1.2 APAC Tissue Mass Spectrometry Imaging System Revenue by Region (2018-2023) 6.2 APAC Tissue Mass Spectrometry Imaging System Sales by Type 6.3 APAC Tissue Mass Spectrometry Imaging System Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Tissue Mass Spectrometry Imaging System by Country 7.1.1 Europe Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023) 7.1.2 Europe Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023) 7.2 Europe Tissue Mass Spectrometry Imaging System Sales by Type 7.3 Europe Tissue Mass Spectrometry Imaging System Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Tissue Mass Spectrometry Imaging System by Country 8.1.1 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023) 8.1.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023) 8.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Type 8.3 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Tissue Mass Spectrometry Imaging System 10.3 Manufacturing Process Analysis of Tissue Mass Spectrometry Imaging System 10.4 Industry Chain Structure of Tissue Mass Spectrometry Imaging System 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Tissue Mass Spectrometry Imaging System Distributors 11.3 Tissue Mass Spectrometry Imaging System Customer 12 World Forecast Review for Tissue Mass Spectrometry Imaging System by Geographic Region 12.1 Global Tissue Mass Spectrometry Imaging System Market Size Forecast by Region 12.1.1 Global Tissue Mass Spectrometry Imaging System Forecast by Region (2024-2029) 12.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Tissue Mass Spectrometry Imaging System Forecast by Type 12.7 Global Tissue Mass Spectrometry Imaging System Forecast by Application 13 Key Players Analysis 13.1 Standard BioTools 13.1.1 Standard BioTools Company Information 13.1.2 Standard BioTools Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.1.3 Standard BioTools Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Standard BioTools Main Business Overview 13.1.5 Standard BioTools Latest Developments 13.2 Waters Corporation 13.2.1 Waters Corporation Company Information 13.2.2 Waters Corporation Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.2.3 Waters Corporation Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Waters Corporation Main Business Overview 13.2.5 Waters Corporation Latest Developments 13.3 Ionpath 13.3.1 Ionpath Company Information 13.3.2 Ionpath Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.3.3 Ionpath Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Ionpath Main Business Overview 13.3.5 Ionpath Latest Developments 13.4 JEOL 13.4.1 JEOL Company Information 13.4.2 JEOL Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.4.3 JEOL Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 JEOL Main Business Overview 13.4.5 JEOL Latest Developments 13.5 SHIMADZU 13.5.1 SHIMADZU Company Information 13.5.2 SHIMADZU Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.5.3 SHIMADZU Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 SHIMADZU Main Business Overview 13.5.5 SHIMADZU Latest Developments 13.6 TransMIT GmbH 13.6.1 TransMIT GmbH Company Information 13.6.2 TransMIT GmbH Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.6.3 TransMIT GmbH Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 TransMIT GmbH Main Business Overview 13.6.5 TransMIT GmbH Latest Developments 13.7 Thermo Fisher Scientific 13.7.1 Thermo Fisher Scientific Company Information 13.7.2 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.7.3 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Thermo Fisher Scientific Main Business Overview 13.7.5 Thermo Fisher Scientific Latest Developments 13.8 Impact Scientific Instrument 13.8.1 Impact Scientific Instrument Company Information 13.8.2 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.8.3 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Impact Scientific Instrument Main Business Overview 13.8.5 Impact Scientific Instrument Latest Developments 13.9 mProbe 13.9.1 mProbe Company Information 13.9.2 mProbe Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications 13.9.3 mProbe Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 mProbe Main Business Overview 13.9.5 mProbe Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
LP Information 社の最新刊レポート本レポートと同じKEY WORD(tissue)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/08 10:26 154.13 円 166.76 円 202.76 円 |